Ioakeim-Ioannidou et al., 2023 - Google Patents
Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patientsIoakeim-Ioannidou et al., 2023
View HTML- Document ID
- 1183331133358895084
- Author
- Ioakeim-Ioannidou M
- Niemierko A
- Kim D
- Tejada A
- Urell T
- Leahy S
- Adams J
- Fullerton B
- Nielsen G
- Hung Y
- Shih A
- Patino M
- Buch K
- Rincon S
- Kelly H
- Cunnane M
- Tolia M
- Widemann B
- Wedekind M
- John L
- Ebb D
- Shin J
- Cote G
- Curry W
- MacDonald S
- Publication year
- Publication venue
- Neuro-oncology
External Links
Snippet
Background Data on clinical outcomes for base of skull (BOS) chordomas in the pediatric population is limited. We report patient outcomes after surgery and proton radiotherapy (PRT). Methods Pediatric patients with BOS chordomas were treated with PRT or combined …
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/103—Treatment planning systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1077—Beam delivery systems
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Al-Omair et al. | Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy | |
| Johnson et al. | Long term results of primary radiosurgery for vestibular schwannomas | |
| Hartgerink et al. | Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions | |
| Sahgal et al. | Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes | |
| Hansasuta et al. | Multisession stereotactic radiosurgery for vestibular schwannomas: single-institution experience with 383 cases | |
| Hanakita et al. | The long-term outcomes of radiosurgery for intracranial hemangioblastomas | |
| Popp et al. | Hippocampus‐avoidance whole‐brain radiation therapy with a simultaneous integrated boost for multiple brain metastases | |
| Chan et al. | Reirradiation with intensity‐modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma | |
| Inoue et al. | Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis | |
| Ioakeim-Ioannidou et al. | Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patients | |
| Westover et al. | Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer | |
| Weber et al. | Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute | |
| Yamazaki et al. | Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer | |
| Hall et al. | Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases | |
| Bessa et al. | Consensus in bladder cancer research priorities between patients and healthcare professionals using a four-stage modified Delphi method | |
| Hartgerink et al. | A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases | |
| Onodera et al. | Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution | |
| Puataweepong et al. | Radiation‐Induced Peripheral Malignant Nerve Sheath Tumor Arising from Vestibular Schwannoma after Linac‐Based Stereotactic Radiation Therapy: A Case Report and Review of Literatures | |
| De et al. | Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation | |
| Nakaji et al. | Resection and surgically targeted radiation therapy for the treatment of larger recurrent or newly diagnosed brain metastasis: results from a prospective trial | |
| Hayashi et al. | Hyperfractionated high-dose proton beam radiotherapy for clival chordomas after surgical removal | |
| Redmond et al. | Single versus multiple session stereotactic body radiotherapy for spinal metastasis: the risk–benefit ratio | |
| Takagawa et al. | Radiotherapy for localized sebaceous carcinoma of the eyelid: a retrospective analysis of 83 patients | |
| Upadhyay et al. | Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors | |
| Braam et al. | Stereotactic versus conventional radiotherapy for pain reduction and quality of life in spinal metastases: study protocol for a randomized controlled trial |